Showing results (91-100 of 373) with videos related to

Sort By:
Pageof 38
Evolutionary Applications|February 12, 2013
Modelling the evolution of genetic instability during tumour progressionRuchira S Datta, Alice Gutteridge, Charles Swanton, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2018
An Economical, Quantitative, and Robust Protocol for High-Throughput T Cell Receptor Sequencing from Tumor or BloodImran Uddin, Kroopa Joshi, Theres Oakes, et al.
Current Opinion in Pharmacology|May 14, 2013
Tumour heterogeneity and immune-modulationMariam Jamal-Hanjani, Eirini Thanopoulou, Karl S Peggs, et al.
British Journal of Cancer|May 15, 2023
Modelled mortality benefits of multi-cancer early detection screening in EnglandPeter Sasieni, Rebecca Smittenaar, Earl Hubbell, et al.
The Oncologist|October 25, 2011
Integrating molecular mechanisms and clinical evidence in the management of trastuzumab resistant or refractory HER-2⁺ metastatic breast cancerHilda Wong, Roland Leung, Ava Kwong, et al.
Annual Review of Genetics|October 9, 2014
Cancer: evolution within a lifetimeMarco Gerlinger, Nicholas McGranahan, Sally M Dewhurst, et al.
European Urology|August 28, 2016
The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven TherapeuticsChristopher E Barbieri, Arul M Chinnaiyan, Seth P Lerner, et al.
Open Biology|January 13, 2021
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectoriesRobert E Hynds, Kristopher K Frese, David R Pearce, et al.
Molecular & Cellular Oncology|December 20, 2023
APOBEC3 as a driver of genetic intratumor heterogeneitySubramanian Venkatesan, Mihaela Angelova, Jirina Bartkova, et al.
Science Translational Medicine|April 17, 2015
Clonal status of actionable driver events and the timing of mutational processes in cancer evolutionNicholas McGranahan, Francesco Favero, Elza C de Bruin, et al.
Pageof 38